Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study

被引：0
|
作者：
Yanjun Xu
Zhiyu Huang
Hongyang Lu
Xinming Yu
Yuping Li
Wenfeng Li
Jun Chen
Ming Chen
Lei Gong
Kaiyan Chen
Jin Qin
Xiaoling Xu
Ying Jin
Jun Zhao
Xun Shi
Na Han
Fajun Xie
Peng Zhang
Weizhen Xu
Yun Fan
机构：
[1] Zhejiang Cancer Hospital,Department of Medical Thoracic Oncology
[2] The First Affiliated Hospital of Wenzhou Medical University,Department of Pulmonary and Critical Care Medicine
[3] Yinzhou People’s Hospital,Department of Radiotherapy and Chemotherapy
[4] Zhejiang Cancer Hospital,Department of Radiation Oncology
[5] Good Clinical Practice Center of Zhejiang Cancer Hospital,Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer
[6] Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute),undefined
来源：
British Journal of Cancer | 2019年 / 121卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：640 / 646
页数：6
相关论文
共 50 条
  • [1] Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study
    Xu, Yanjun
    Huang, Zhiyu
    Lu, Hongyang
    Yu, Xinming
    Li, Yuping
    Li, Wenfeng
    Chen, Jun
    Chen, Ming
    Gong, Lei
    Chen, Kaiyan
    Qin, Jin
    Xu, Xiaoling
    Jin, Ying
    Zhao, Jun
    Shi, Xun
    Han, Na
    Xie, Fajun
    Zhang, Peng
    Xu, Weizhen
    Fan, Yun
    [J]. BRITISH JOURNAL OF CANCER, 2019, 121 (08) : 640 - 646
  • [2] "Highly Exposed Chinese Herbal Medicine" Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
    Wang, Mingqi
    Jiang, Haili
    Zhang, Mei
    Chen, Yang
    Wang, Ting
    Li, Ping
    [J]. DOSE-RESPONSE, 2021, 19 (04):
  • [3] Anlotinib as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer: A Single-arm, Prospective, Phase II Study
    Kong, F.
    Wang, Z.
    Wang, N.
    Zhang, D.
    Liao, D.
    Zhang, J.
    Su, C.
    Jia, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S691 - S692
  • [4] Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II, single-arm, exploratory research
    Zhao, Y.
    Liu, J.
    Li, X.
    Li, Y.
    Pu, H.
    Wang, X.
    Yang, M.
    Bai, S.
    Guo, L.
    Zhao, L.
    Zhang, M.
    Zhao, H.
    Xu, S.
    Wang, Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1674 - S1674
  • [5] Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
    Aktas, Gokmen
    Kus, Tulay
    Kalender, Mehmet Emin
    Sevinc, Alper
    Camci, Celaletdin
    Kul, Seval
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 1921 - 1926
  • [6] Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
    Zugazagoitia, Jon
    Paz-Ares, Luis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 671 - +
  • [7] A Single-Arm Multi-Center Phase II Study of Apatinib in Patients with ES-SCLC After Second/Third-Line Chemotherapy
    Fan, Y.
    Huang, Z.
    Li, W.
    Li, Y.
    Chen, J.
    Xu, Y.
    Lu, H.
    Yu, X.
    Xu, Y.
    Qin, J.
    Jin, Y.
    Xu, X.
    Gong, L.
    Xie, F.
    Han, N.
    Zhang, P.
    Chen, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S573 - S573
  • [8] First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer.
    Shi, Jian
    Liu, Jiayin
    Duan, Xiaoyang
    Huang, Guanglei
    Wang, Lixing
    Zhao, Yan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] First-Line Envafolimab plus Carboplatin-etoposide in Extensive-Stage Small-Cell Lung Cancer: a Single-Arm Phase II Study
    Sun, S.
    Zhao, X.
    Zhang, J.
    Zhang, X.
    Han, Q.
    Yan, X.
    Zhu, Y.
    Wang, J.
    Jiao, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S371 - S371
  • [10] A Phase II Single-Arm Trial of Apatinib as Maintenance Treatment Following First-Line Chemotherapy in Extensive Stage Small Cell Lung Cancer
    Teng, F.
    Xing, P.
    Wang, Y.
    Hu, X.
    Lin, L.
    Li, J.
    Hao, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1190 - S1190
12345